Neurodegenerative diseases.

Pharmaceuticals.

TdeltaS is committed to developing science-based proprietary products that sit at the interface of food and pharmaceuticals - nutraceuticals - and offer real improvement in human physical and mental performance.

Pre-clinical stage biotechnology company which aims to deliver innovative cancer care to patients.

Developing innovative therapeutics in oncology and behavioural brain disorders.

A software development company that produce clinical trial data. In 2005 Third Phase Ltd merged with the Cmed Group Ltd. Third Phase Limited Merges with Cmed Group October 2005.

Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.

Immunology.

Echo Machine Learning Assay

The company has been formed around two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer.

All-in-one recruitment platform with video capacity.

Velocys, previously Oxford Catalysts, produces speciality catalysts for the generation of clean fuels, from both conventional fossil fuels and renewable sources such as biomass.

Domain-centric intelligent automated data extraction methodology.

Nanoparticles for cancer therapy, imaging and drug delivery.

YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.

Commercialising T cell receptor-based immunotherapy for multiple indications.

Data discovery software to manage and sort collections of images and data visually.

Modification of proteins.